Achillion Announces the Promotion of Milind S. Deshpande, Ph.D. to Executive Vice President of Research
Dr. Deshpande joined Achillion as Vice President of Chemistry in September 2001. He was named Head of Drug Discovery in April 2002, and promoted to Vice President of Drug Discovery in December 2002. Prior to joining Achillion, Dr. Deshpande was Associate Director in Chemistry at the Pharmaceutical Research Institute at Bristol-Myers Squibb, where he managed the identification of new clinical candidates to treat infectious and neurological diseases. Before that, Dr. Deshpande held a faculty position at Boston University Medical School. Following his undergraduate education in India, Dr. Deshpande received his Ph.D. in Organic Chemistry from Ohio University.
In May 2007, Dr. Deshpande temporarily assumed leadership of Achillion's clinical development activities upon the resignation of John Pottage, Jr., M.D., as Senior Vice President and Chief Medical Officer. He will retain these responsibilities while the Company continues its search for a new chief medical officer.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.